​
Login / Signup
Stephanie C Pitts
ORCID
Publication Activity (10 Years)
Years Active: 2024-2024
Publications (10 Years): 6
Top Topics
Squamous Cell
Poor Prognosis
Small Molecule
Chemotherapy Induced
Top Venues
Journal of experimental & clinical cancer research : CR
Clinical and translational medicine
</>
This page only lists publications with an associated author ORCID identifier.
Publications
</>
Stephanie C Pitts
,
Jeffrey Schlom
,
Renee N Donahue
Soluble immune checkpoints: implications for cancer prognosis and response to immune checkpoint therapy and conventional therapies.
Journal of experimental & clinical cancer research : CR
43 (1) (2024)
Stephanie C Pitts
,
Jeffrey Schlom
,
Renee N Donahue
Soluble immune checkpoints: implications for cancer prognosis and response to immune checkpoint therapy and conventional therapies.
Journal of experimental & clinical cancer research : CR
43 (1) (2024)
Meghali Goswami
,
Nicole J Toney
,
Stephanie C Pitts
,
Carolina Celades
,
Jeffrey Schlom
,
Renee N Donahue
Peripheral immune biomarkers for immune checkpoint inhibition of solid tumours.
Clinical and translational medicine
14 (8) (2024)
Meghali Goswami
,
Nicole J Toney
,
Stephanie C Pitts
,
Carolina Celades
,
Jeffrey Schlom
,
Renee N Donahue
Peripheral immune biomarkers for immune checkpoint inhibition of solid tumours.
Clinical and translational medicine
14 (8) (2024)
Stephanie C Pitts
,
Jeffrey Schlom
,
Renee N Donahue
Soluble immune checkpoints: implications for cancer prognosis and response to immune checkpoint therapy and conventional therapies.
Journal of experimental & clinical cancer research : CR
43 (1) (2024)
Meghali Goswami
,
Nicole J Toney
,
Stephanie C Pitts
,
Carolina Celades
,
Jeffrey Schlom
,
Renee N Donahue
Peripheral immune biomarkers for immune checkpoint inhibition of solid tumours.
Clinical and translational medicine
14 (8) (2024)